Inheritance of high and low HDL: mechanisms and management

Area of Science:

• Cardiovascular Genetics
• Lipid Metabolism
• Atherosclerosis Research

Background:

• Epidemiological studies confirm an inverse relationship between plasma high-density lipoprotein cholesterol (HDL-C) and cardiovascular disease (CVD) incidence.
• Genetic disorders influencing HDL-C levels can confer atheroprotection or predispose individuals to premature atherosclerosis.
• Despite the established link, no pharmacological intervention targeting HDL-C has definitively proven to prevent CVD progression.

Purpose of the Study:

• To review recent findings on the inheritance patterns of genetic disorders associated with varying HDL-C plasma levels.
• To discuss the clinical features of these genetic HDL disorders.
• To explore emerging HDL-C-targeted therapies currently in clinical trials for CVD prevention.

Main Methods:

• Literature review of recent research on genetic disorders of HDL.
• Analysis of studies examining inheritance of high and low HDL-C levels.
• Discussion of clinical manifestations and therapeutic strategies.

Main Results:

• Primary genetic HDL disorders can be linked to longevity or lead to premature CVD, resulting in significant morbidity and mortality.
• Recent research has identified promising therapeutic strategies for patients at risk of CVD.
• Understanding the genetic basis of HDL disorders is crucial for revealing molecular targets for novel drug discovery.

Conclusions:

• Clarifying the mechanisms of inheritance in genetic HDL disorders is a key research goal.
• New therapeutic strategies targeting HDL-C show promise for future CVD management.
• Further research into HDL metabolism and function can lead to novel medications for CVD prevention and treatment.